Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Time on Our Side

Despite a number of technical obstacles, fragment screening is gradually gaining in popularity particularly in the wake of recent advances in dynamic injection methods. Eric Reese from SensiQ Technologies reports.

Eric Reese, SensiQ Technologies (September 2014)

Keywords: Fragment-based drug design, Surface plasmon resonance, Low-affinity compounds, Injection techniques, Actives selection

    View full article    |    Back to Discovery Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |